نتایج جستجو برای: kshv

تعداد نتایج: 1599  

2014
Da-Jiang Li Dinesh Verma Tim Mosbruger Sankar Swaminathan

Kaposi's sarcoma-associated herpesvirus (KSHV) is a human herpesvirus that causes Kaposi's sarcoma and is associated with the development of lymphoproliferative diseases. KSHV reactivation from latency and virion production is dependent on efficient transcription of over eighty lytic cycle genes and viral DNA replication. CTCF and cohesin, cellular proteins that cooperatively regulate gene expr...

2015
Erica L. Sanchez Patrick A. Carroll Angel B. Thalhofer Michael Lagunoff Dirk P. Dittmer

Kaposi's Sarcoma-associated Herpesvirus (KSHV) is the etiologic agent of Kaposi's Sarcoma (KS). KSHV establishes a predominantly latent infection in the main KS tumor cell type, the spindle cell, which is of endothelial cell origin. KSHV requires the induction of multiple metabolic pathways, including glycolysis and fatty acid synthesis, for the survival of latently infected endothelial cells. ...

Journal: :Journal of virology 2004
Feng-Chun Ye Fu-Chun Zhou Seung Min Yoo Jian-Ping Xie Philip J Browning Shou-Jiang Gao

Latent nuclear antigen (LNA) is implicated in Kaposi's sarcoma-associated herpesvirus (KSHV) episome persistence. LNA colocalizes with KSHV episomes on chromosomes in metaphase, and it maintains the stability and replication of KSHV terminal repeat-containing plasmids. In this study, we examined the function of LNA in episome persistence in the context of full-length KSHV genome by mutagenesis ...

2017
Anne K Barasa Peng Ye Meredith Phelps Ganapathiram T Arivudainambi Timelia Tison Javier Gordon Ogembo

Infection with Kaposi sarcoma-associated herpesvirus (KSHV) is estimated to account for over 44,000 new cases of Kaposi sarcoma annually, with 84% occurring in Africa, where the virus is endemic. To date, there is no prophylactic vaccine against KSHV. KSHV gpK8.1, gB, and gH/gL glycoproteins, implicated in the virus entry into host cells, are attractive vaccine targets for eliciting potent neut...

2017
Dhivya Ramalingam Joseph M. Ziegelbauer

Kaposi's sarcoma-associated herpesvirus (KSHV) encodes 12 pre-microRNAs during latency that are processed to yield ~25 mature microRNAs (miRNAs). We were interested in identifying cellular networks that were targeted by KSHV-miRNAs and employed network building strategies using validated KSHV miRNA targets. Here, we report the identification of a gene network centering on the transcription fact...

Journal: :Acta virologica 2014
L R Hwang S Cha J E Jong J H Jang T Seo

Kaposi's sarcoma-associated herpesvirus (KSHV) is a pathogenic agent of Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease in humans. Similarly to other gammaherpesviruses such as Epstein-Barr virus (EBV) and herpesvirus saimiri (HVS), KSHV displays two alternative life cycles, latent and lytic one. The transactivation from latency to the lytic phase is the result ...

2012
Tracie Delgado Erica L. Sanchez Roman Camarda Michael Lagunoff

Like cancer cells, virally infected cells have dramatically altered metabolic requirements. We analyzed global metabolic changes induced by latent infection with an oncogenic virus, Kaposi's Sarcoma-associated herpesvirus (KSHV). KSHV is the etiologic agent of Kaposi's Sarcoma (KS), the most common tumor of AIDS patients. Approximately one-third of the nearly 200 measured metabolites were alter...

2011
Guillaume Suffert Georg Malterer Jean Hausser Johanna Viiliäinen Aurélie Fender Maud Contrant Tomi Ivacevic Vladimir Benes Frédéric Gros Olivier Voinnet Mihaela Zavolan Päivi M. Ojala Juergen G. Haas Sébastien Pfeffer

Kaposi's sarcoma herpesvirus (KSHV) encodes a cluster of twelve micro (mi)RNAs, which are abundantly expressed during both latent and lytic infection. Previous studies reported that KSHV is able to inhibit apoptosis during latent infection; we thus tested the involvement of viral miRNAs in this process. We found that both HEK293 epithelial cells and DG75 cells stably expressing KSHV miRNAs were...

2012
Terri A. DiMaio Michael Lagunoff

Kaposi's sarcoma (KS) is a highly vascularized tumor supporting large amounts of neo-angiogenesis. The major cell type in KS tumors is the spindle cell, a cell that expresses markers of lymphatic endothelium. KSHV, the etiologic agent of KS, is found in the spindle cells of all KS tumors. Considering the extreme extent of angiogenesis in KS tumors at all stages it has been proposed that KSHV di...

2017
Enrique Fuentes-Mattei Dana Elena Giza Masayoshi Shimizu Cristina Ivan John T. Manning Stefan Tudor Maria Ciccone Osman Aykan Kargin Xinna Zhang Pilar Mur Nayra Soares do Amaral Meng Chen Jeffrey J. Tarrand Florea Lupu Alessandra Ferrajoli Michael J. Keating Catalin Vasilescu Sai-Ching Jim Yeung George A. Calin

Prevalence of Kaposi sarcoma-associated herpesvirus (KSHV/HHV-8) varies greatly in different populations. We hypothesized that the actual prevalence of KSHV/HHV8 infection in humans is underestimated by the currently available serological tests. We analyzed four independent patient cohorts with post-surgical or post-chemotherapy sepsis, chronic lymphocytic leukemia and post-surgical patients wi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید